Publications

Drug Information Group faculty regularly publish articles on a variety of topics in peer-reviewed journals and other educational formats.

Recent Publications (2014 - Present) Heading link

  • Elste JM, Phillips J. A summary of selected 2023-2024 FDA MedWatch Alerts. Pharmacy Practice News. September 12, 2024. Available at: https://www.pharmacypracticenews.com/Clinical/Article/09-24/A-Summary-of-Selected-2023-2024-FDA-MedWatch-Alerts/74748
  • Johnson ST, Goldwire MA, Abdalla M, Advani A, Alhammad AM, Anderson KC, Bernknopf A, Blommel ML, Brunner R, Frazier J, Gor P, Gosser R, Ipema H, Kier KL, Kostrzewa A, Majerczyk D, Manian R, Maxwell E, May D, May JR, Munir F, Okafar I, Phillips J, Poore AA, Saad M, Sibbesen JB, Sommer CD. Teaching learners to identify and reduce the spread of medical misinformation. J Am Coll Clin Pharm. Published online July 31, 2024.
  • Harris IM, Hilaire ML, Jeon M, Kier KL, Munir F, Carmon AS, Maffei MV, Mukherjee SM. Pharmacists’ role in combating medical misinformation. J Am Coll Clin Pharm. Published online July 3, 2024.
  • Johnson ST, Goldwire MA, Abdalla M, Al-Shehre WH, Bernknopf A, Colella A, Denton C, Douglas JS, Gosser R, Heindel G, Holsopple M, Ipema H, Kier K, Kostrzewa A, Majerczyk D, May D, May JR, Mersek ST, Munir F, Saad M, Sommer CD, Thornby K, Ward KE. PRN Opinion Paper | Drug Information: From Education to Practice – 2024 Update – an opinion paper of the Drug Information Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2024;7(5):492-504.
  • Krueger C, Syeda A. Overview of Long-Acting Injectable Schizophrenia Medication. Pharmacy Practice News. June 7, 2024. Available at: https://www.pharmacypracticenews.com/Clinical/Article/06-24/Overview-of-Long-Acting-Injectable-Schizophrenia-Medications/74012
  • Munir F, Gehres A, Wai D, Song L. Evaluation of ChatGPT as a tool for answering clinical questions in pharmacy practice. J Pharm Pract. Published online May 22, 2024.
  • Rodriguez R, Joseph H, Macrito R, Lee TA, Sweiss K. Risk prediction models for antineoplastic-associated cardiotoxicity in treatment of breast cancer: A systematic review. Am J Health Syst Pharm. 2023;80(19):1315-1325.
  • Sarna K, Phillips J. The Pharmacist’s Role in Ensuring Safe and Effective Use Of Approved Cannabis Therapies. Pharmacy Practice News. November 20, 2023. Available at: https://www.pharmacypracticenews.com/Clinical/Article/11-23/The-Pharmacists-Role-in-Ensuring-Safe-and-Effective-Use-Of-Approved-Cannabis-Therapies/71910
  • Griggs L, Phillips J. Drug allergy practice parameter update: focus on antibiotics. KeePosted. 2023;49(3):26-29.
  • Adebogun O, Phillips J.  The pharmacist’s role in applying the updated Beers Criteria.  KeePosted. 2023;49(4):30-32.
  • Phillips J. Medical misinformation: the power of influence. J Am Coll Clin Pharm. 2023;6(5):444-445.
  • Elste J, Ipema H, Denton C, Munir F, et al. Light-sensitive injectable prescription drugs – 2022. Hosp Pharm. 2023;58(5):448-475.
  • Ipema HJ, Elste J, Koppen L, Soni R, et al. Inclusion of optimal guidelines for pharmacists in UpToDate. Ann Pharmacother. 2022;56(9):1084-1085.
  • Rodriguez R, Brunner R, Spencer S, et al. Time to inclusion in clinical guidance documents for non-oncological orphan drugs and biologics with expedited FDA designations: a retrospective survival analysis. BMJ Open. 2021;11(12):e057744.
  • Brunner R, Gerberich A. Managing Pain in Parkinson’s Disease. Practical Pain Management. 2021;21(1). Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/managing-pain-parkinson-disease
  • Gerberich A, Ipema HJ. A primer on ocular viscosurgical devices. Am J Health Syst Pharm. 2021;78(22):2020-2032.
  • Joseph H, Gabay M. CDC Opioid Prescribing Guideline: Clinical Concerns Lead to Revision. Practical Pain Management. 2021;21(6). Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/cdc-opioid-prescribing-guideline-clinical-concerns-lead-revision
  • West-Thielke PM, Ipema HJ, Campbell-Lee S, et al. Removal of anti-thymocyte globulin by plasma exchange in ABO-incompatible and positive crossmatch kidney transplant recipients. Transplant Proc. 2021;53(5):1548-1553.
  • Bursua A, Mudreac A, Koppen L, Larson C, Park YS, Sreedhar R. Effect of default order standardization on opioid prescribing patterns. Jt Comm J Qual Patient Saf. 2021;47(7):431-437.
  • Sarna K. Best practices for monitoring hazardous drug surface contamination: a guidance for health care institutions. Pharmacy Practice News. July 23, 2020. Available at: https://www.pharmacypracticenews.com/Review-Articles/Article/07-20/Best-Practices-for-Monitoring-Hazardous-Drug-Surface-Contamination/58875
  • Sarna K. Hyperkalemia management: role of the pharmacist in optimization of care. Pharmacy Practice News. March 19, 2020. Available at: https://www.pharmacypracticenews.com/Clinical/Article/03-20/Hyperkalemia-Management/57443
  • Nathan J, Grossman S, Ness G, Gabay M, Ipema H, Tierno H.  Update on the status of drug information centers in the United States.  Am J Health Syst Pharm. 2020;77(1):33-38.
  • Sarna KV, Griffin T, Tarlov E, Gerber BS, Gabay MP, Suda KJ.  Trends in gender composition on editorial boards in leading medicine nursing, and pharmacy journals.  J Am Pharm Assoc. 2020;60(4):565-570.
  • Spencer SH, Menard SM, Labedz MZ, Krueger CD, Sarna KV. Enteral tube administration of oral chemotherapy drugs. J Oncol Pharm Pract. 2020;26(3):703-717.
  • Ipema H, Zacher J, Galka E, Nazari J, Varabyeva A, Yu M, Hartke P. Drugs to be used with a filter for preparation and/or administration-2019. Hosp Pharm. 2021;56(2):81-87.
  • Miles K, Zacher J. A physician primer: drugs with orphan designations for the treatment of pain conditions. Practical Pain Management. 2019. Available at: https://www.practicalpainmanagement.com/resources/practice-management/physician-primer-drugs-orphan-designations-treatment-pain-conditions?fbclid=IwAR00bFHTLtzYJvpnDRYaDA4H1TZC0Gota6X1Zf1pNmui04XB-POuOmBIaVg
  • Gerberich A, Spencer S, Ipema H. National Guideline Clearinghouse is no more – keep calm and search on. Ann Pharmacother. 2019;53(4):434-436.
  • Rodriguez R, Koppen L, Patel YA, Ellinger, LK. Characteristics of shortage-related drug information requests and recommendations from a nationally-serving drug information center. Am J Health Syst Pharm. 2019;76(23):1900-1902.
  • Sarna KV, Gross AE. Vancomycin versus metronidazole for non-severe Clostridioides difficile infection: are the data adequate to change practice? Ann Pharmacother. 2019;53(8):845-852.
  • Rasmussen JT, Ipema HJ. Formulary considerations for insulins approved through the 505(b)(2) ‘follow-on’ pathway. Ann Pharmacother. 2019;53(2):204-210.
  • Koppen L, Suda K, Rowan S, McGregor J, Evans C. Dentists’ prescribing of antibiotics and opioids to Medicare Part D beneficiaries: medications of high impact to public health. J Am Dent Assoc. 2018;149(8):721-730.
  • Spencer S, Ipema H, Hartke P, Krueger C, Rodriguez R, Gross AE, Gabay M. Intravenous push administration for antibiotics: An alternative method. Hosp Pharm. 2018;53(3):157-169.
  • Koppen L, Whitaker A, Rosene A, Beckett R. Effect of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968.
  • Rodriguez R, Soni R. Psoriatic arthritis: established, newer, and emerging therapies. Practical Pain Management. 2017;17(6). Available at: https://www.practicalpainmanagement.com/pain/myofascial/inflammatory-arthritis/psoriatic-arthritis-established-newer-emerging-therapies.
  • Koppen L, Afanasjeva J. A brief history of the FDA’s role in the ongoing effort to ensure safe opioid use. Practical Pain Management. 2017;17(1). Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/brief-history-fda-role-ongoing-effort-ensure-safe-opioid-use.
  • Bursua A, Hartke PL, Larson CM. Benchmarking and medication error rates. Am J Health Syst Pharm. 2016;73(11):744.
  • Hartke P, Afanasjeva J. Sports-related pain: topical treatments. Practical Pain Management. 2016;16(4). Available at: http://www.practicalpainmanagement.com/treatments/pharmacological/non-opioids/sports-related-pain-topical-treatments.
  • Hartke PL, Vermeulen LC, Hoffman JM, et al. Accuracy of prescription drug expenditure forecasts published in the AJHP. Am J Health Syst Pharm. 2015;72(19):1642-1648.
  • Koppen L, Phillips J, Papageorgiou R. Analysis of reference sources used in drug-related Wikipedia articles. J Med Libr Assoc. 2015;103(3):140-144.
  • Zych K, Ipema H. Psoriasis and psoriatic arthritis: update in management. Specialty Pharmacy Continuum. January/February 2016. Available at: http://www.specialtypharmacycontinuum.com/download/psoriasis_spc0116_WM.pdf.
  • Ghaibi S, Ipema HJ, Gabay MG. ASHP guideline on the pharmacist’s role in providing drug information. Am J Health Syst Pharm. 2015;72(7):573-577.
  • Ipema HJ, Tanzi MG. Medical writing and peer review. In: Gabay M, ed. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning; 2015.
  • Krueger C. New treatments for rheumatoid arthritis. Specialty Pharmacy Continuum. 2014;4(3):8-10.
  • Fisseha N, Rodriguez R, Ipema H. Olysio (simeprevir) Review. Illinois Pharmacist. 2014;26(2):26-27.
  • UIC Drug Information Group. Light-sensitive injectable prescription drugs. Hosp Pharm. 2014;49(2):136-163.